Notice of Results
Scancell Holdings plc will announce its interim financial results for the six months ended 31 October 2025 on Thursday, 29 January 2026, and will also provide a business update. The company, which develops active immunotherapies for cancer, will host a live webcast for analysts and investors at 14:00 GMT on the day of the results. This announcement is a notice of upcoming financial reporting and an investor presentation, with no specific financial figures for the interim period yet disclosed.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), the developer of active immunotherapies to treat cancer, will announce its interim financial results for the six months ended 31 October 2025 and provide a business update on progress achieved post-period, on Thursday 29 January 2026.
Phillip L'Huillier, Chief Executive Officer, and Sath Nirmalananthan, Chief Financial Officer, will host a live webcast for analysts and investors on the day of the results at 14:00 GMT.
If you would like to join the webcast, please follow this link:
| Interim Financial Results for the six months ending 31 October 2025 | SparkLive | LSEG |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.